ML22277A818

From kanterella
Jump to navigation Jump to search
Federal Register Notice and Order - Shine Technologies, LLC, Extension of Construction Date and Name Change
ML22277A818
Person / Time
Site: SHINE Medical Technologies
Issue date: 12/05/2022
From: Joshua Borromeo
NRC/NRR/DANU/UNPL
To:
References
NRC-2022-0180
Download: ML22277A818 (11)


Text

[7590-01-P]

NUCLEAR REGULATORY COMMISSION

[Docket No. 50-608; NRC-2022-0180]

In the Matter of SHINE Medical Technologies, LLC

SHINE Medical Isotope Production Facility

AGENCY: Nuclear Regulatory Commission.

ACTION: Order; issuance.

SUMMARY

The U.S. Nuclear Regulatory Commission (NRC) has approved the S HINE

Medical Technologies, LLC (SHINE) request to amend Construction Permit No. CPMIF-

001 for the SHINE Medical Isotope Production Facility (SHINE fa cility) in Rock County,

Wisconsin. The approved amendments extend the latest date for completion of the

construction of the SHINE facility from December 31, 2022, to D ecember 31, 2025, and

administratively change the name of the construction permit hol der from SHINE Medical

Technologies, LLC to SHINE Technologies, LLC.

DATE: The Order was issued on November 30, 2022.

ADDRESSES: Please refer to Docket ID NRC-2022-0180 when contacting the NRC

about the availability of information regarding this document. You may obtain publicly

available information related to this document using any of the following methods:

search for Docket ID NRC-2022-0180. Address questions about Docket IDs in

Regulations.gov to Stacy Schumann; telephone: 301-415-0624; em ail:

Stacy.Schumann@nrc.gov. For technical questions, contact the i ndividual listed in the

For Further Information Contact section of this document.

  • NRCs Agencywide Documents Access and Management System

(ADAMS): You may obtain publicly available documents online in the ADA MS Public Documents collection at https://www.nrc.gov/reading-rm/adams.ht ml. To begin the

search, select Begin Web-based ADAMS Search. For problems wi th ADAMS, please

contact the NRCs Public Document Room (PDR) reference staff at 1-800-397-4209,

301-415-4737, or by email to PDR.Resource@nrc.gov. The SHINE r equest to amend

Construction Permit No. CPMIF-001 is available in ADAMS under A ccession No.

ML22091A093.

  • NRCs PDR: You may examine and purchase copies of public documents,

by appointment, at the NRCs PDR, Room P1 B35, One White Flint North, 11555

Rockville Pike, Rockville, Maryland 20852. To make an appointm ent to visit the PDR,

please send an email to PDR.Resource@nrc.gov or call 1-800-397-4209 or 301-415-

4737, between 8:00 a.m. and 4:00 p.m. Eastern Time, Monday thr ough Friday, except

Federal holidays.

FOR FURTHER INFORMATION CONTACT: Holly Cruz, Office of Nuclear Reactor

Regulation, U.S. Nuclear Regulatory Commission, Washington, DC 20555-0001;

telephone: 301-415-1053; email: Holly.Cruz@nrc.gov.

SUPPLEMENTARY INFORMATION: The text of the Order is attached.

Dated: December 5, 2022.

For the Nuclear Regulatory Commission.

/RA

Joshua M. Borromeo, Chief, Non-Power Production and Utilization Facilities Licensing Branch, Division of Advanced Reactors and Non-Power Production and Utilization Facilities, Office of Nuclear Reactor Regulation.

2 UNITED STATES OF AMERICA

NUCLEAR REGULATORY COMMISSION

In the Matter of )

)

SHINE Medical Technologies, LLC ) Docket No. 50-608

) Construction Permit No. CPMIF-001 (SHINE Medical Isotope Production Facility) )

ORDER

I.

SHINE Medical Technologies, LLC (SHINE, licensee, permit holder ) is the holder

of Construction Permit (CP) No. CPMIF-001, which the U.S. Nucle ar Regulatory

Commission (NRC, the Commission) issued on February 29, 2016 (A gencywide

Documents Access and Management System (ADAMS) Package Accessio n No.

ML16041A473), for the construction of the SHINE Medical Isotope Production Facility

(SHINE facility) in Rock County, Wisconsin. CP No. CPMIF-001 in cludes December 31,

2022 as the latest date for completion of the construction of t he SHINE facility and

expires on the latest date of completion. The SHINE facility is currently under

construction.

By letter dated April 1, 2022 (ML22091A093), SHINE submitted to the NRC a

license amendment request in accordance with section 50.90, Ap plication for

amendment of license, construction permit, or early site permit, of title 10 of the Code of

Federal Regulations (10 CFR) and 10 CFR 50.55(b). The license amendment request

seeks to extend the latest date for completion of the construct ion of the SHINE facility

from December 31, 2022, to December 31, 2025, and to change the name of the CP

holder from SHINE Medical Technologies, LLC to SHINE Technologi es, LLC. SHINE

stated that the proposed name change is administrative because it does not involve any 3

transfer of control of the CP or a change to ownership, organiz ation, rights, or liabilities

of SHINE.

II.

Upon review of the license amendment request, the NRC staff det ermined that

SHINE had shown good cause for extending the latest date for co mpletion of the

construction of the SHINE facility from December 31, 2022, to D ecember 31, 2025 and

that the name change of the CP holder from SHINE Medical Techno logies, LLC to

SHINE Technologies, LLC is administrative in nature. The staff also determined that the

license amendment request involves no significant hazards consi deration. The staff

prepared an environmental assessment and finding of no signific ant impact for the

requested extension of the latest date for completion of constr uction and published it in

the Federal Register on November 10, 2022 (87 FR 67965). On the basis of the

environmental assessment, the staff concluded that the requeste d extension will not

have a significant effect on the quality of the human environme nt. The findings set forth

above are supported by an NRC staff safety evaluation dated Nov ember 30, 2022, which

is available at ML22292A319.

III.

Within 60 days after the date of publication of this notice, an y persons (petitioner)

whose interest may be affected by this action may file a reques t for a hearing and

petition for leave to intervene (petition) with respect to the action. The scope of this order

extending the latest date for completion of construction and ad ministratively changing

the name of the CP holder and any proceeding hereunder is limit ed to direct challenges

to the CP holders asserted reasons that show good cause for th e extension and to the

name change. Petitions shall be filed in accordance with the Co mmissions Agency

Rules of Practice and Procedure in 10 CFR part 2. Interested p ersons should consult a

4 current copy of 10 CFR 2.309. The NRCs regulations are accessi ble electronically from

the NRC Library on the NRCs website at https://www.nrc.gov/rea ding-

rm/doccollections/cfr/. Alternat ively, a copy of the regulations is available at the NRCs

Public Document Room, located at One White Flint North, Room P1 B35, 11555

Rockville Pike, Rockville, Maryland 20852. If a petition is fil ed, the Commission or a

presiding officer will rule on the petition and, if appropriate, a notice of a hearing will be

issued.

As required by 10 CFR 2.309(d), the petition should specificall y explain the

reasons why intervention should be permitted with particular re ference to the following

general requirements for standing: (1) the name, address, and t elephone number of the

petitioner; (2) the nature of the petitioners right to be made a party to the proceeding; (3)

the nature and extent of the petitioners property, financial, or other interest in the

proceeding; and (4) the possible effect of any decision or orde r which may be entered in

the proceeding on the petitioners interest.

In accordance with 10 CFR 2.309(f), the petition must also set forth the specific

contentions which the petitioner seeks to have litigated in the proceeding. Each

contention must consist of a specific statement of the issue of law or fact to be raised or

controverted. In addition, the petitioner must provide a brief explanation of the bases for

the contention and a concise statement of the alleged facts or expert opinion which

support the contention and on which the petitioner intends to r ely in proving the

contention at the hearing. The petitioner must also provide ref erences to the specific

sources and documents on which the petitioner intends to rely t o support its position on

the issue. The petition must include sufficient information to show that a genuine dispute

exists with the applicant or licensee on a material issue of la w or fact. Contentions must

be limited to matters within the scope of the proceeding. The c ontention must be one

5 which, if proven, would entitle the petitioner to relief. A pet itioner who fails to satisfy the

requirements at 10 CFR 2.309(f) with respect to at least one co ntention will not be

permitted to participate as a party.

Those permitted to intervene become parties to the proceeding, subject to any

limitations in the order granting leave to intervene. Parties h ave the opportunity to

participate fully in the conduct of the hearing with respect to resolution of that partys

admitted contentions, including the opportunity to present evid ence, consistent with the

NRCs regulations, policies, and procedures.

Petitions must be filed no later than 60 days from the date of publication of this

notice. Petitions and motions for leave to file new or amended contentions that are filed

after the deadline will not be entertained absent a determinati on by the presiding officer

that the filing demonstrates good cause by satisfying the three factors in 10 CFR

2.309(c)(1)(i) through (iii). The petition must be filed in acc ordance with the filing

instructions in the section of this document discussing electro nic submissions (E-Filing).

If a hearing is requested, and the Commission has not made a fi nal

determination on the issue of no significant hazards considerat ion, the Commission will

make a final determination on the issue of no significant hazar ds consideration. The final

determination will serve to establish when the hearing is held. If the final determination is

that the amendment request involves no significant hazards cons ideration, the

Commission may issue the amendment and make it immediately effe ctive,

notwithstanding the request for a hearing. Any hearing would ta ke place after issuance

of the amendment. If the final determination is that the amendm ent request involves a

significant hazards consideration, then any hearing held would take place before the

issuance of the amendment unless the Commission finds an immine nt danger to the

health or safety of the public, in which case it will issue an appropriate order or rule

6 under 10 CFR part 2.

A State, local governmental body, Federally recognized Indian T ribe, or agency

thereof, may submit a petition to the Commission to participate as a party under 10 CFR

2.309(h)(1). The petition should state the nature and extent of the petitioners interest in

the proceeding. The petition should be submitted to the Commiss ion no later than 60

days from the date of publication of this notice. The petition must be filed in accordance

with the filing instructions in the section of this document di scussing electronic

submissions (E-Filing), and shoul d meet the requirements for petitions set forth in this

section, except that under 10 CFR 2.309(h)(2) a State, local go vernmental body, or

Federally recognized Indian Tribe, or agency thereof does not n eed to address the

standing requirements in 10 CFR 2.309(d) if the facility is loc ated within its boundaries.

Alternatively, a State, local governmental body, Federally recognized Indian Tribe, or

agency thereof may participate as a non-party under 10 CFR 2.31 5(c).

If a hearing is granted, any person who is not a party to the p roceeding and is not

affiliated with or represented by a party may, at the discretio n of the presiding officer, be

permitted to make a limited appearance pursuant to the provisio ns of 10 CFR 2.315(a).

A person making a limited appearance may make an oral or writte n statement of his or

her position on the issues but may not otherwise participate in the proceeding. A limited

appearance may be made at any session of the hearing or at any prehearing

conference, subject to the limits and conditions as may be impo sed by the presiding

officer. Details regarding the opportunity to make a limited ap pearance will be provided

by the presiding officer if such sessions are scheduled.

IV.

All documents filed in NRC adjudicatory proceedings, including a request for

hearing and petition for leave to intervene (petition), any motion or other document filed

7 in the proceeding prior to the submission of a request for hear ing or petition to intervene,

and documents filed by interested governmental entities that re quest to participate under

10 CFR 2.315(c), must be filed in accordance with the NRCs E-F iling rule (72 FR

49139; August 28, 2007, as amended at 77 FR 46562; August 3, 20 12). The E-Filing

process requires participants to submit and serve all adjudicat ory documents over the

internet, or in some cases to mail copies on electronic storage media. Detailed guidance

on making electronic submissions may be found in the Guidance f or Electronic

Submissions to the NRC and on the NRC website at https://www.nr c.gov/site-

help/esubmittals.html. Participants may not submit paper copies of their filings unless

they seek an exemption in accordance with the procedures descri bed below.

To comply with the procedural requirements of E-Filing, at leas t 10 days prior to

the filing deadline, the participant should contact the Office of the Secretary by email at

hearing.docket@nrc.gov, or by telephone at 301-415-1677, to (1) request a digital

identification (ID) certificate, which allows the participant ( or its counsel or

representative) to digitally sign submissions and access the E-Filing system for any

proceeding in which it is participating; and (2) advise the Sec retary that the participant

will be submitting a petition or other adjudicatory document (e ven in instances in which

the participant, or its counsel or representative, already hold s an NRC-issued digital ID

certificate). Based upon this information, the Secretary will e stablish an electronic docket

for the hearing in this proceeding if the Secretary has not alr eady established an

electronic docket.

Information about applying for a digital ID certificate is avai lable on the NRCs

public website at https://www.nrc.gov/site-help/e-submittals/ge tting-started.html. Once a

participant has obtained a digital ID certificate and a docket has been created, the

participant can then submit adjudicatory documents. Submissions must be in Portable

8 Document Format (PDF). Additional guidance on PDF submissions i s available on the

NRCs public website at https://www.nrc.gov/site-help/electroni c-sub-ref-mat.html. A

filing is considered complete at the time the document is submi tted through the NRCs E-

Filing system. To be timely, an electronic filing must be submi tted to the E-Filing system

no later than 11:59 p.m. Eastern Time on the due date. Upon rec eipt of a transmission,

the E-Filing system time-stamps the document and sends the subm itter an email notice

confirming receipt of the document. The E-Filing system also di stributes an email notice

that provides access to the document to the NRCs Office of the General Counsel and

any others who have advised the Office of the Secretary that th ey wish to participate in

the proceeding, so that the filer need not serve the document o n those participants

separately. Therefore, applicants and other participants (or th eir counsel or

representative) must apply for and receive a digital ID certificate before adjudicatory

documents are filed so that they can obtain access to the docum ents via the E-Filing

system.

A person filing electronically u sing the NRCs adjudicatory E-Filing system may

seek assistance by contacting the NRCs Electronic Filing Help Desk through the

Contact Us link located on the NRCs public website at https: //www.nrc.gov/site-

help/e-submittals.html, by email to MSHD.Resource@nrc.gov, or b y a toll-free call at 1-

866-672-7640. The NRC Electronic Filing Help Desk is available between 9 a.m. and 6

p.m., Eastern Time, Monday through Friday, excluding government holidays.

Participants who believe that they have a good cause for not su bmitting

documents electronically must file an exemption request, in acc ordance with 10 CFR

2.302(g), with their initial paper filing stating why there is good cause for not filing

electronically and requesting authorization to continue to subm it documents in paper

format. Such filings must be subm itted by: (1) first class mail addressed to the Office of

9 the Secretary of the Commission, U.S. Nuclear Regulatory Commis sion, Washington,

DC 20555-0001, Attention: Rulemaking and Adjudications Staff; o r (2) courier, express

mail, or expedited delivery service to the Office of the Secret ary, 11555 Rockville Pike,

Rockville, Maryland 20852, Attention: Rulemaking and Adjudicati ons Staff. Participants

filing adjudicatory documents in this manner are responsible fo r serving the document on

all other participants. Filing is considered complete by first-class mail as of the time of

deposit in the mail, or by courier, express mail, or expedited delivery service upon

depositing the document with the provider of the service. A pre siding officer, having

granted an exemption request from using E-Filing, may require a participant or party to

use E-Filing if the presiding officer subsequently determines t hat the reason for granting

the exemption from use of E-Filing no longer exists.

Documents submitted in adjudicatory proceedings will appear in the NRCs

electronic hearing docket which is available to the public at h ttps://adams.nrc.gov/ehd,

unless excluded pursuant to an order of the Commission or the p residing officer. If you

do not have an NRC-issued digital ID certificate as described a bove, click cancel when

the link requests certificates and you will be automatically di rected to the NRCs

electronic hearing dockets where you will be able to access any publicly available

documents in a particular hearing docket. Participants are requ ested not to include

personal privacy information, such as social security numbers, home addresses, or

personal phone numbers in their filings, unless an NRC regulati on or other law requires

submission of such information. For example, in some instances, individuals provide

home addresses in order to demonstrate proximity to a facility or site. With respect to

copyrighted works, except for limited excerpts that serve the p urpose of the adjudicatory

filings and would constitute a Fair Use application, participan ts are requested not to

include copyrighted materials in their submission.

10 The attorney for the CP holder is Nathan Schleifer, General Cou nsel, SHINE

Technologies, LLC, 3400 Innovation Court, Janesville, WI 53546.

V.

Accordingly, pursuant to Sections 161b and 161i of the Atomic E nergy Act of

1954, as amended; 42 U.S.C. Sections 2201(b) and 2201(i); and 1 0 CFR 50.90 and 10

CFR 50.55(b), IT IS HEREBY ORDERED that CP No. CPMIF-001 is ame nded to extend

the latest date for completion of the construction of the SHINE facility from December

31, 2022, to December 31, 2025, and to change the name of the C P holder from SHINE

Medical Technologies, LLC to SHINE Technologies, LLC.

This order is effective upon issuance.

Dated: NOVEMBER 30, 2022.

FOR THE NUCLEAR REGULATORY COMMISSION.

/RA/

Caroline Carusone, Deputy Director, Division of Advanced Reactors and Non-Power Production and Utilization Facilities, Office of Nuclear Reactor Regulation.

11